Oriana Papin-Zoghbi is CEO of AOA Dx, revolutionizing early diagnosis of ovarian cancer. In this episode, Oriana talks about the science behind their groundbreaking, first-of-its-kind liquid biopsy test; how the phenomenal relationship she has with her scientific collaborator has accelerated the quality and pace of their work; and the enormous potential she sees in using their method to increase early diagnosis of this devastating and costly disease, resulting in a reduction of related deaths by as much as fifty percent.
